Urofollitropin for Injection BP 150 IU
$300.00
| Quantity Value | Price | Quantity | Add To Cart |
|---|---|---|---|
| 6 Injection | $300.00 |
|
SKU : N/A
Category : Hormonal
Urofollitropin for Injection BP 150 IU is a prescription fertility medicine containing human follicle-stimulating hormone (FSH), used under medical supervision to support reproductive function in selected infertility treatments.
Product Overview
Urofollitropin for Injection BP 150 IU is a prescription-only hormonal medicine used in the management of certain infertility conditions. It contains urofollitropin, a purified form of human follicle-stimulating hormone (FSH), which plays a vital role in normal reproductive function. This medicine is primarily prescribed as part of assisted reproductive treatment protocols under the supervision of a qualified healthcare professional.
How It Works
Urofollitropin works by mimicking the action of naturally occurring follicle-stimulating hormone in the body. In females, FSH stimulates the growth and maturation of ovarian follicles, which contain eggs necessary for ovulation and fertility. In males, FSH supports sperm production by acting on the seminiferous tubules of the testes. By supplementing FSH levels, urofollitropin helps regulate and support normal reproductive processes when the body’s natural hormone levels are insufficient.
Uses / Indications
Urofollitropin for Injection BP 150 IU is commonly indicated for:
-
Treatment of female infertility associated with ovulatory dysfunction
-
Controlled ovarian stimulation in assisted reproductive techniques such as in vitro fertilization (IVF)
-
Treatment of male infertility related to hypogonadotropic hypogonadism, when used as part of a hormone therapy regimen
The medicine is used based on individual patient evaluation and is not intended for self-medication or non-medical use.
Composition
-
Active Ingredient: Urofollitropin (Human Follicle-Stimulating Hormone)
-
Dosage Form: Powder for solution for injection
-
Strength: 150 IU per vial
The formulation is designed for reconstitution prior to administration and is manufactured according to pharmacopeial standards (BP).
Administration
Urofollitropin for Injection is administered via subcutaneous or intramuscular injection, as determined by the treating physician. Treatment protocols, duration, and monitoring requirements vary depending on the patient’s condition, response to therapy, and treatment goals. Regular clinical monitoring, including hormonal assessments and imaging where appropriate, is essential during therapy to ensure safety and effectiveness.
Storage Instructions
-
Store below 25°C
-
Protect from light
-
Do not freeze
-
Keep out of reach of children
-
Use only if the solution is clear and free from visible particles after reconstitution
Always follow the storage instructions provided on the product packaging.
Important Information / Warning
Urofollitropin for Injection BP 150 IU should be used strictly under medical supervision. Improper use may increase the risk of adverse effects, including ovarian hyperstimulation syndrome (OHSS) in women. The medicine is contraindicated in patients with hormone-dependent tumors, unexplained vaginal bleeding, or primary ovarian failure. Prior medical evaluation and ongoing monitoring are essential throughout treatment.
For general educational information on fertility hormones and their medical use, patients may refer to trusted sources such as MedlinePlus by the U.S. National Library of Medicine:
https://medlineplus.gov/infertility.html
| Pack Size |
6 Injection |
|---|
